Turning Point Brands, Inc. (TPB)
NYSEConsumer StaplesTobaccoSnapshot 2026-11-05
$67.47-4.16%
Close 2026-11-05 · 1-day change
NYSEConsumer StaplesTobaccoSnapshot 2026-11-05
QuarterlyIQ Insights · TPB
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
ex_969512.htm Exhibit 99.1 Turning Point Brands Announces Second Quarter 2026 Results [TABLE] ● | Q2 2026 Modern Oral Gross Revenue increased 149% to $87.0 million and Net Sales increased 128% to $68…
Stated in 2 of 2 supplied quarters. Management reported: “Performance Measures in the Second Quarter Investment in the quarter focused on sales and marketing efforts to support distribution and brand building.” “In the second quarter, consolidated selling, general and administrative (“SG&A”) expenses increased 91.1% from the prior year to $76.9 million, inclusive of Modern Oral-related sales and marketing investments and increased outbound freight costs.”
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Consumer Staples names rated neutral grew net income 49% of the time over the next year (vs 61% for the rest of the cohort, n=2777).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“ex_969512.htm Exhibit 99.1 Turning Point Brands Announces Second Quarter 2026 Results [TABLE] ● | Q2 2026 Modern Oral Gross Revenue increased 149% to $87.0 million and Net Sales increased 128% to $68…”
“ex_930472.htm Exhibit 99.1 Turning Point Brands Announces First Quarter 2026 Results ● Q1 2026 Modern Oral Net Sales increased 133% to $52.0 million, accounting for 42% of total company net sales, up…”
Performance Measures in the Second Quarter Investment in the quarter focused on sales and marketing efforts to support distribution and brand building.
Stated in 2 of 2 supplied quarters. Management reported: “Performance Measures in the Second Quarter Investment in the quarter focused on sales and marketing efforts to support distribution and brand building.” “In the second quarter, consolidated selling, general and administrative (“SG&A”) expenses increased 91.1% from the prior year to $76.9 million, inclusive of Modern Oral-related sales and marketing investments and increased outbound freight costs.”
“Performance Measures in the Second Quarter Investment in the quarter focused on sales and marketing efforts to support distribution and brand building.”
“Performance Measures in the First Quarter Investment in the first quarter focused on sales and marketing efforts to support distribution and brand building.”
As of June 30, 2026, ending cash was $268.3 million and net debt was $31.7 million, inclusive of approximately $59.6 million of equity raised during the quarter to support long term strategic objecti…
Stated in 2 of 2 supplied quarters. Management reported: “As of June 30, 2026, ending cash was $268.3 million and net debt was $31.7 million, inclusive of approximately $59.6 million of equity raised during the quarter to support long term strategic objectives.” “The company’s total liquidity is $339.0 million, which includes $70.7 million of availability on an asset backed revolving credit facility.”
“As of June 30, 2026, ending cash was $268.3 million and net debt was $31.7 million, inclusive of approximately $59.6 million of equity raised during the quarter to support long term strategic objecti…”
“As of March 31, 2026 , ending cash was $192.4 million and net debt was $101.4 million.”
Meet or exceed the full-year 2026 Adjusted EBITDA guidance range, inclusive of investments in Modern Oral sales and marketing.
Manage CEO transition smoothly to maintain operational stability and strategic focus.
Over the trailing year it converted 0.62x of net income into operating cash flow. Historically, Consumer Staples names rated fragile grew net income 47% of the time over the next year (vs 58% for the rest of the cohort, n=1558).
Not enough signal yet.
Not enough signal to read sensitivity to the US dollar, the broad stock market, long-term interest rates, real (inflation-adjusted) rates, Fed net liquidity (low R² over the window).
8 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Consumer Staples names rated stable grew net income 54% of the time over the next year (vs 57% for the rest of the cohort, n=1938).
Not investment advice. As of 2026-11-05.